An estimated 25.8 million children and adults in the United States—8.3% of the population—have diabetes. The U.S. Food and Drug Administration (FDA) warned patients that use of the diabetes drug Actos (pioglitazone) may be linked to an increased risk of bladder cancer if taken for a year or more. Information about this risk was added to the Warnings and Precautions section of the Actos label in ...